Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Pharmaceutical Fine Chemicals Market Report by Type (Proprietary, Non-proprietary), Product (Active Ingredients, Basic Building Blocks, Advanced Intermediates), Size (Big Molecules, Small Molecules), Application (Cardiovascular, Neurological, Oncological, Respiratory, Gastrointestinal, Musculoskeletal, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A5910
Buy Now
Market Overview:
The global pharmaceutical fine chemicals market size reached US$ 141.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 233.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2023
|
|
Forecast Years
|
2024-2032
|
|
Historical Years
|
2018-2023
|
| Market Size in 2023 | US$ 141.1 Billion |
| Market Forecast in 2032 | US$ 233.9 Billion |
| Market Growth Rate (2024-2032) | 5.7% |
Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.
.webp)
Pharmaceutical Fine Chemicals Market Trends:
The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product, size and application.
Breakup by Type:
- Proprietary
- Non-proprietary
Breakup by Product:
- Active Ingredients
- Basic Building Blocks
- Advanced Intermediates
Breakup by Size:
- Big Molecules
- Small Molecules
Breakup by Application:
- Cardiovascular
- Neurological
- Oncological
- Respiratory
- Gastrointestinal
- Musculoskeletal
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).
Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | US$ Billion |
| Segment Coverage | Type, Product, Size, Application, Region |
| Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered | BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.) |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global pharmaceutical fine chemicals market was valued at US$ 141.1 Billion in 2023.
We expect the global pharmaceutical fine chemicals market to exhibit a CAGR of 5.7% during 2024-2032.
The rising prevalence of various neurological and cardiovascular diseases, especially among the geriatric population, along with the continuous development of proprietary and non-proprietary product variants, is primarily driving the global pharmaceutical fine chemicals market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of pharmaceutical fine chemicals for producing novel vaccines and drugs to combat the spread of the coronavirus infection.
Based on the type, the global pharmaceutical fine chemicals market can be segmented into proprietary and non-proprietary. Currently, proprietary holds the majority of the total market share.
Based on the product, the global pharmaceutical fine chemicals market has been divided into active ingredients, basic building blocks, and advanced intermediates. Among these, active ingredients currently exhibit a clear dominance in the market.
Based on the size, the global pharmaceutical fine chemicals market can be categorized into big molecules and small molecules. Currently, big molecules account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Asia-Pacific currently dominates the global market.
Some of the major players in the global pharmaceutical fine chemicals market include BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation), and W. R. Grace and Co. (Standard Industries Inc.).
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More